Table of Contents Author Guidelines Submit a Manuscript
Anesthesiology Research and Practice
Volume 2013 (2013), Article ID 750901, 10 pages
http://dx.doi.org/10.1155/2013/750901
Review Article

Copper and Anesthesia: Clinical Relevance and Management of Copper Related Disorders

1Department of Anesthesia, Queen Elizabeth II Jubilee Hospital, Locked Bag 2 ARCHERFIELD, Coopers Plains, QLD 4108, Australia
2Department of Chemistry, Saint Francis University, P.O. Box 600, Loretto, PA 15940-0600, USA

Received 28 February 2013; Accepted 16 April 2013

Academic Editor: Kouichiro Minami

Copyright © 2013 Adrian Langley and Charles T. Dameron. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. G. Fraga, “Relevance, essentiality and toxicity of trace elements in human health,” Molecular Aspects of Medicine, vol. 26, no. 4-5, pp. 235–244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Itoh, W. K. Ha, O. Nakagawa et al., “Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation,” Journal of Biological Chemistry, vol. 283, no. 14, pp. 9157–9167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Boyuk, O. Banli, M. Gumus et al., “Plasma levels of zinc, copper, and ceruloplasmin in patients after undergoing laparoscopic adjustable gastric banding,” Biological Trace Element Research, vol. 143, no. 3, pp. 1282–1288, 2011. View at Publisher · View at Google Scholar
  4. D. Beshgetoor and M. Hambidge, “Clinical conditions altering copper metabolism in humans,” American Journal of Clinical Nutrition, vol. 67, no. 5, pp. 1017S–1021S, 1998. View at Google Scholar · View at Scopus
  5. B. R. Stern, M. Solioz, D. Krewski et al., “Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships,” Journal of Toxicology and Environmental Health B, vol. 10, no. 3, pp. 157–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. A. Cockell, J. Bertinato, and M. R. L'Abbé, “Regulatory frameworks for copper considering chronic exposures of the population,” American Journal of Clinical Nutrition, vol. 88, no. 3, pp. 863S–866S, 2008. View at Google Scholar · View at Scopus
  7. D. G. Barceloux, “Copper,” Journal of Toxicology, vol. 37, no. 2, pp. 217–230, 1999. View at Publisher · View at Google Scholar
  8. R. A. Wapnir, “Copper absorption and bioavailability,” American Journal of Clinical Nutrition, vol. 67, supplement 5, pp. 1054S–1060S, 1998. View at Google Scholar
  9. M. Arredondo and M. T. Nunez, “Iron and copper metabolism,” Molecular Aspects of Medicine, vol. 26, no. 4-5, pp. 313–327, 2005. View at Publisher · View at Google Scholar
  10. P. V. E. van den Berghe and L. W. J. Klomp, “New developments in the regulation of intestinal copper absorptionn,” Nutrition Reviews, vol. 67, no. 11, pp. 658–672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Kehrer, “The Haber-Weiss reaction and mechanisms of toxicity,” Toxicology, vol. 149, no. 1, pp. 43–50, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Prohaska, “Biochemical changes in copper deficiency,” Journal of Nutritional Biochemistry, vol. 1, no. 9, pp. 452–461, 1990. View at Publisher · View at Google Scholar
  13. C. T. Dameron and M. D. Harrison, “Mechanisms for protection against copper toxicity,” American Journal of Clinical Nutrition, vol. 67, no. 5, pp. 1091S–1097S, 1998. View at Google Scholar · View at Scopus
  14. H. J. McArdle, H. S. Andersen, H. Jones, and L. Gambling, “Copper and iron transport across the placenta: regulation and interactions,” Journal of Neuroendocrinology, vol. 20, no. 4, pp. 427–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. G. Kaler, “Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency,” American Journal of Clinical Nutrition, vol. 67, no. 5, pp. 1029S–1034S, 1998. View at Google Scholar · View at Scopus
  16. B. C. Kirodian, N. J. Gogtay, V. P. Udani, and N. A. Kshirsagar, “Treatment of menkes disease with parenteral copper histidine,” Indian Pediatrics, vol. 39, no. 2, pp. 183–185, 2002. View at Google Scholar · View at Scopus
  17. E. A. Roberts and B. Sarkar, “Liver as a key organ in the supply, storage, and excretion of copper,” American Journal of Clinical Nutrition, vol. 88, no. 3, pp. 851S–584S, 2008. View at Google Scholar · View at Scopus
  18. A. Ala, A. P. Walker, K. Ashkan, J. S. Dooley, and M. L. Schilsky, “Wilson's disease,” The Lancet, vol. 369, no. 9559, pp. 397–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. J. Brewer, “Recognition, diagnosis, and management of Wilson's disease,” Proceedings of the Society for Experimental Biology and Medicine, vol. 223, no. 1, pp. 39–46, 2000. View at Publisher · View at Google Scholar
  20. D. B. Milne, “Copper intake and assessment of copper status,” American Journal of Clinical Nutrition, vol. 67, no. 5, pp. 1041S–1045S, 1998. View at Google Scholar · View at Scopus
  21. I. Iakovidis, I. Delimaris, and S. M. Piperakis, “Copper and its complexes in medicine: a biochemical approach,” Molecular Biology International, vol. 2011, Article ID 594529, 13 pages, 2011. View at Publisher · View at Google Scholar
  22. M. Olivares, M. A. Mendez, P. A. Astudillo et al., “Present situation of biomarkers for copper status,” American Journal of Clinical Nutrition, vol. 88, no. 3, pp. 859S–862S, 2008. View at Google Scholar
  23. S. G. Kaler, C. S. Holmes, D. S. Goldstein et al., “Neonatal diagnosis and treatment of Menkes disease,” New England Journal of Medicine, vol. 358, no. 6, pp. 605–614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Arnon, J. F. Calderon, M. Schilsky, S. Emre, and B. L. Shneider, “Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment,” Journal of Pediatric Gastroenterology and Nutrition, vol. 44, no. 5, pp. 596–602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Sözeri, D. Feist, H. Ruder, and K. Schärer, “Proteinuria and other renal functions in Wilson's disease,” Pediatric Nephrology, vol. 11, no. 3, pp. 307–311, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. E. A. Roberts and M. L. Schilsky, “Diagnosis and treatment of Wilson disease: an update,” Hepatology, vol. 47, no. 6, pp. 2089–2111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Madsen and J. D. Gitlin, “Copper and iron disorders of the brain,” Annual Review of Neuroscience, vol. 30, pp. 317–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Aedo, R. Delgado, D. Wolff, and C. Vergara, “Copper and zinc as modulators of neuronal excitability in a physiologically significant concentration range,” Neurochemistry International, vol. 50, no. 4, pp. 591–600, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Delgado, C. Vergara, and D. Wolff, “Divalent cations as modulators of neuronal excitability: emphasis on copper and zinc,” Biological Research, vol. 39, no. 1, pp. 173–182, 2006. View at Google Scholar · View at Scopus
  30. H. T. Liu, M. W. Hollmann, W. H. Liu, C. W. Hoenemann, and M. E. Durieux, “Modulation of NMDA receptor function by ketamine and magnesium: part I,” Anesthesia and Analgesia, vol. 92, no. 5, pp. 1173–1181, 2001. View at Google Scholar · View at Scopus
  31. M. L. Schlief and J. D. Gitlin, “Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus,” Molecular Neurobiology, vol. 33, no. 2, pp. 81–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Lutsenko, A. Bhattacharjee, and A. L. Hubbard, “Copper handling machinery of the brain,” Metallomics, vol. 2, no. 9, pp. 596–608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Desai and S. G. Kaler, “Role of copper in human neurological disorders,” American Journal of Clinical Nutrition, vol. 88, no. 3, pp. 855S–888S, 2008. View at Google Scholar · View at Scopus
  34. J. C. Tan, D. L. Burns, and H. R. Jones, “Severe ataxia, myelopathy, and peripheral neuropathy due to acquired copper deficiency in a patient with history of gastrectomy,” Journal of Parenteral and Enteral Nutrition, vol. 30, no. 5, pp. 446–450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Kumar, “Copper deficiency myelopathy (human swayback),” Mayo Clinic Proceedings, vol. 81, no. 10, pp. 1371–1384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. T. Saari and D. A. Schuschke, “Cardiovascular effects of dietary copper deficiency,” BioFactors, vol. 10, no. 4, pp. 359–375, 1999. View at Google Scholar · View at Scopus
  37. J. D. Hicks, A. Donsante, T. M. Pierson et al., “Increased frequency of congenital heart defects in Menkes disease,” Clinical Dysmorphology, vol. 21, no. 2, pp. 59–63, 2012. View at Publisher · View at Google Scholar
  38. Z. Hlubocka, Z. Marecek, A. Linhart et al., “Cardiac involvement in Wilson disease,” Journal of Inherited Metabolic Disease, vol. 25, no. 4, pp. 269–277, 2002. View at Publisher · View at Google Scholar
  39. S. T. Zhang, X. G. Li, and C. H. Liu, “Effects of copper chloride on electromechanical activities of myocardial cells,” Zhongguo Yao Li Xue Bao, vol. 11, pp. 166–168, 1990. View at Google Scholar
  40. Y. F. Qi and X. P. Che, “Effects of Cu2+ on the neuromuscular junction transmission,” Acta Pharmaceutica Sinica, vol. 27, no. 2, pp. 81–85, 1992. View at Google Scholar · View at Scopus
  41. N. Prasun, M. Bagchi, A. Joseph et al., “Recurrent bleeding and bulbar myasthenia-like symptoms as the initial presentation of Wilson's disease: a case report,” Neurology Asia, vol. 16, no. 2, pp. 167–169, 2011. View at Google Scholar · View at Scopus
  42. F. Agertt, A. C. S. Crippa, P. J. Lorenzoni et al., “Menkes' disease: case report,” Arquivos de Neuro-Psiquiatria, vol. 65, no. 1, pp. 157–160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Zhang, J. Lv, and S. Sun, “Elements in lung tissues of patients from a high lung cancer incidence area of China,” Biological Trace Element Research, vol. 148, no. 1, pp. 7–10, 2012. View at Google Scholar
  44. A. C. Tanrikulu, A. Abakay, O. Evliyaoglu et al., “Coenzyme Q10, copper, zinc, and lipid peroxidation levels in serum of patients with chronic obstructive pulmonary disease,” Biological Trace Element Research, vol. 143, no. 2, pp. 659–667, 2011. View at Publisher · View at Google Scholar
  45. V. L. Kinnula and J. D. Crapo, “Superoxide dismutases in the lung and human lung diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 12, pp. 1600–1619, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Mizuno, M. Yasuo, H. J. Bogaard et al., “Copper deficiency induced emphysema is associated with focal adhesion kinase inactivation,” PLoS One, vol. 7, Article ID e30678, 2012. View at Google Scholar
  47. J. D. Tobias, “Anaesthetic considerations in the child with Menkes' syndrome,” Canadian Journal of Anaesthesia, vol. 39, no. 7, pp. 712–715, 1992. View at Google Scholar · View at Scopus
  48. M. Passariello, N. Almenrader, and P. Pietropaoli, “Anesthesia for a child with Menkes disease,” Paediatric Anaesthesia, vol. 18, no. 12, pp. 1225–1226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. B. de Souza Hobaika, “Anesthesia for a patient with Wilson's disease—a case report,” Middle East Journal of Anesthesiology, vol. 19, no. 4, pp. 905–908, 2008. View at Google Scholar · View at Scopus
  50. M. Baykal and S. Karapolat, “Anesthetic management of a pediatric patient with wilsons disease,” Journal of Clinical Medicine Research, vol. 2, no. 2, pp. 99–101, 2010. View at Google Scholar
  51. R. Vaja, L. McNicol, and I. Sisley, “Anaesthesia for patients with liver disease,” Continuing Education in Anaesthesia, Critical Care and Pain, vol. 10, no. 1, Article ID mkp040, pp. 15–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Narayanan, G. Chetan, and S. Mahadevan, “Wilson's disease presenting as respiratory failure,” Indian Journal of Pediatrics, vol. 73, no. 1, pp. 99–100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. M. S. Mandell, “Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era,” Liver Transplantation, vol. 10, no. 10, pp. S54–S58, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. S. S. Percival, “Copper and immunity,” American Journal of Clinical Nutrition, vol. 67, supplement 5, pp. 1064S–1068S, 1998. View at Google Scholar
  55. M. Bonham, J. M. O'Connor, B. M. Hannigan, and J. J. Strain, “The immune system as a physiological indicator of marginal copper status?” British Journal of Nutrition, vol. 87, no. 5, pp. 393–403, 2002. View at Google Scholar · View at Scopus
  56. C. White, J. Lee, T. Kambe, K. Fritsche, and M. J. Petris, “A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity,” Journal of Biological Chemistry, vol. 284, no. 49, pp. 33949–33956, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. J. R. Turnlund, R. A. Jacob, C. L. Keen et al., “Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men,” American Journal of Clinical Nutrition, vol. 79, no. 6, pp. 1037–1044, 2004. View at Google Scholar · View at Scopus
  58. A. Czlonkowska and B. Milewski, “Immunological observations on patients with Wilson's disease,” Journal of the Neurological Sciences, vol. 29, no. 2–4, pp. 411–421, 1976. View at Google Scholar · View at Scopus
  59. P. Milkiewicz, S. Saksena, S. G. Hubscher, and E. Elias, “Wilson's disease with superimposed autoimmune features: report of two cases and review,” Journal of Gastroenterology and Hepatology, vol. 15, no. 5, pp. 570–574, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. R. G. Santos, F. Alissa, J. Reyes, L. Teot, and N. A. Ameen, “Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation,” Pediatric Transplantation, vol. 9, no. 1, pp. 112–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. O. Imataki, H. Ohnishi, A. Kitanaka, Y. Kubota, T. Ishida, and T. Tanaka, “Pancytopenia complicated with peripheral neuropathy due to copper deficiency: clinical diagnostic review,” Internal Medicine, vol. 47, no. 23, pp. 2063–2065, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Sharma, A. Toppo, B. Rath, A. Harbhajanka, and P. Lalita Jyotsna, “Hemolytic anemia as a presenting feature of wilson's disease: a case report,” Indian Journal of Hematology and Blood Transfusion, vol. 26, no. 3, pp. 101–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. K. F. Adams, G. Johnson Jr., K. E. Hornowski, and T. H. Lineberger, “The effect of copper on erythrocyte deformability. A possible mechanism of hemolysis in acute copper intoxication,” Biochim Biophys Acta, vol. 550, no. 2, pp. 279–287, 1979. View at Google Scholar · View at Scopus
  64. G. J. S. Cooper, “Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and alzheimers disease,” Drugs, vol. 71, no. 10, pp. 1281–1320, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Y. Goh and M. E. Cooper, “The role of advanced glycation end products in progression and complications of diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 4, pp. 1143–1152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Linz, N. L. Barnes, A. M. Zimnicka, J. H. Kaplan, B. Eipper, and S. Lutsenko, “Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney,” American Journal of Physiology, vol. 294, no. 1, pp. F53–F61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. X. H. Zhuang, Y. Mo, X. Y. Jiang et al., “Analysis of renal impairment in children with Wilson's disease,” World Journal of Pediatrics, vol. 4, no. 2, pp. 102–105, 2008. View at Publisher · View at Google Scholar
  68. J. H. Sondheimer, S. K. Mahajan, D. L. Rye et al., “Elevated plasma copper in chronic renal failure,” American Journal of Clinical Nutrition, vol. 47, no. 5, pp. 896–899, 1988. View at Google Scholar · View at Scopus
  69. K. J. Ashok, M. P. Sajida, and S. Joseph, “Plasma ceruloplasmin in chronic renal failure patients undergoing haemodialysis,” Journal of Clinical and Diagnostic Research, vol. 4, no. 1, pp. 2058–2060, 2010. View at Google Scholar · View at Scopus
  70. J. E. Kiss, D. Berman, and D. Van Thiel, “Effective removal of copper by plasma exchange in fulminant Wilson's disease,” Transfusion, vol. 38, no. 4, pp. 327–331, 1998. View at Google Scholar · View at Scopus
  71. J. Vukelic, A. Kapamadzija, D. Petrovic et al., “Variations of serum copper values in pregnancy,” Srpski Arhiv za Celokupno Lekarstvo, vol. 140, no. 1-2, pp. 42–46, 2012. View at Publisher · View at Google Scholar
  72. C. V. Iseminger, C. M. Anderson, and W. T. Johnson, “Placenta copper transport proteins in preeclampsia,” Journal of Federation of American Societies for Experimental Biology, vol. 24, p. 609.5, 2010. View at Google Scholar
  73. C. L. Keen, J. Y. Uriu-Hare, S. N. Hawk et al., “Effect of copper deficiency on prenatal development and pregnancy outcome,” American Journal of Clinical Nutrition, vol. 67, no. 5, pp. 1003S–1011S, 1998. View at Google Scholar · View at Scopus
  74. L. R. Walker, M. Rattigan, and J. Canterino, “A case of isolated elevated copper levels during pregnancy,” Journal of Pregnancy, vol. 2011, Article ID 385767, 3 pages, 2011. View at Publisher · View at Google Scholar
  75. J. W. Crayton and W. J. Walsh, “Elevated serum copper levels in women with a history of post-partum depression,” Journal of Trace Elements in Medicine and Biology, vol. 21, no. 1, pp. 17–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Duncan and A. R. White, “Copper complexes as therapeutic agents,” Metallomics, vol. 4, no. 2, pp. 127–138, 2012. View at Publisher · View at Google Scholar
  77. C. T. Dillon, T. W. Hambley, B. J. Kennedy, P. A. Lay, J. E. Weder, and Q. Zhou, “Copper and zinc complexes as antiinflammatory drugs,” Metal Ions in Biological Systems, vol. 41, pp. 253–277, 2004. View at Google Scholar · View at Scopus
  78. N. Jiménez-Garrido, L. Perelló, R. Ortiz et al., “Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin,” Journal of Inorganic Biochemistry, vol. 99, no. 3, pp. 677–689, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. W. Szczepanik, P. Kaczmarek, and M. Jezowska-Bojczuk, “Oxidative activity of copper(II) complexes with aminoglycoside antibiotics as implication to the toxicity of these drugs,” Bioinorganic Chemistry and Applications, vol. 2, no. 1-2, pp. 55–68, 2004. View at Google Scholar · View at Scopus
  80. M. M. Correia dos Santos, V. Famila, and M. L. Simões Gonçalves, “Copper-psychoactive drug complexes: a voltammetric approach to complexation by 1,4-benzodiazepines,” Analytical Biochemistry, vol. 303, no. 2, pp. 111–119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Okuyama, S. Hashimoto, and H. Aihara, “Copper complexes of non-steroidal antiinflammatory agents: analgesic activity and possible opioid receptor activation,” Agents and Actions, vol. 21, no. 1-2, pp. 130–144, 1987. View at Google Scholar · View at Scopus
  82. N. L. Salazar-Weber and J. P. Smith, “Copper inhibits NMDA receptor-independent LTP and modulates the paired-pulse ratio after LTP in mouse hippocampal slices,” International Journal of Alzheimer's Disease, vol. 2011, Article ID 864753, 10 pages, 2011. View at Publisher · View at Google Scholar
  83. R. A. Harris, S. John Mihic, J. E. Dildy-Mayfield, and T. K. Machu, “Actions of anesthetics on ligand-gated ion channels: role of receptor subunit composition,” FASEB Journal, vol. 9, no. 14, pp. 1454–1462, 1995. View at Google Scholar · View at Scopus
  84. D. Bousquet-Moore, X. M. Ma, E. A. Nillni et al., “Reversal of physiological deficits caused by diminished levels of peptidylglycine α-amidating monooxygenase by dietary copper,” Endocrinology, vol. 150, no. 4, pp. 1739–1747, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Wu, M. Ricker, and J. Muench, “Copper deficiency as cause of unexplained hematologic and neurologic deficits in patient with prior gastrointestinal surgery,” Journal of the American Board of Family Medicine, vol. 19, no. 2, pp. 191–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Shander, M. Javidroozi, S. Ozawa et al., “What is really dangerous: anaemia or transfusion?” British Journal of Anaesthesia, vol. 107, supplement 1, pp. 41–59, 2011. View at Publisher · View at Google Scholar
  87. K. E. Littlewood, “The immunocompromised adult patient and surgery,” Best Practice and Research, vol. 22, no. 3, pp. 585–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. J. R. Hebl, S. L. Kopp, D. R. Schroeder, and T. T. Horlocker, “Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy,” Anesthesia and Analgesia, vol. 103, no. 5, pp. 1294–1299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. J. E. Schabel, “Subarachnoid block for a patient with progressive chronic inflammatory demyelinating polyneuropathy,” Anesthesia and Analgesia, vol. 93, no. 5, pp. 1304–1306, 2001. View at Google Scholar · View at Scopus
  90. M. Hughes, I. S. Grant, B. Biccard, and G. Nimmo, “Suxamethonium and critical illness polyneuropathy,” Anaesthesia and Intensive Care, vol. 27, no. 6, pp. 636–638, 1999. View at Google Scholar · View at Scopus
  91. C. Scurr, B. Sampson, J. Ball, and C. Gabriel, “Copper deficiency myeloneuropathy in a patient with haemachromatosis: a case report,” Cases Journal, vol. 2, no. 8, p. 6168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. J. R. Sneyd, “Propofol and epilepsy,” British Journal of Anaesthesia, vol. 82, no. 2, pp. 168–169, 1999. View at Google Scholar · View at Scopus
  93. D. S. Ramchandra, V. Anisya, and M. Gourie-Devi, “Ketamine monoanaesthesia for diagnostic muscle biopsy in neuromuscular disorders in infancy and childhood: floppy infant syndrome,” Canadian Journal of Anaesthesia, vol. 37, no. 4, pp. 474–476, 1990. View at Google Scholar · View at Scopus
  94. B. Plaud, O. Meretoja, R. Hofmockel et al., “Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients,” Anesthesiology, vol. 110, no. 2, pp. 284–294, 2009. View at Publisher · View at Google Scholar · View at Scopus